Bandhauer Benedikt, Gruber Philipp, Andereggen Lukas, Berberat Jatta, Wanderer Stefan, Cattaneo Marco, Schubert Gerrit A, Remonda Luca, Marbacher Serge, Grüter Basil E
1Department of Neurosurgery, Cantonal Hospital Aarau, Switzerland.
2Department of Radiology, Division of Neuroradiology, Cantonal Hospital Aarau, Switzerland.
J Neurosurg. 2024 Sep 27;142(3):619-625. doi: 10.3171/2024.6.JNS24568. Print 2025 Mar 1.
Indication for treatment of unruptured intracranial aneurysms (UIAs) is based on several factors, such as patient age, previous medical history, and UIA location and size. For patients harboring UIAs initially managed noninvasively, the treatment strategy during follow-up (FU) can be changed to include surgical or endovascular intervention. This study aims to identify characteristic patterns and potential predictors of UIAs that require revision of the initial management strategy.
The authors identified intracranial aneurysm (IA) cases newly diagnosed between 2006 and 2022 and initially assigned conservative management. These cases were retrospectively reviewed for 1) patient and UIA characteristics at the time of diagnosis (patient age, comorbidities, previous medical history, potential risk factors, as well as UIA angioarchitecture, location, and size), and 2) any changes in treatment strategy (reason for change, time until intervention, modality of intervention).
Among 1041 IA cases diagnosed in the study period, 144 were initially assigned conservative management. In 10 (6.9%) of these 144 cases, the treatment indication was modified to microsurgical clipping (n = 6) or endovascular embolization (n = 4) after a median FU of 26 months (IQR 8.5-64.5 months). In these 10 cases, the indication for intervention was attributable to IA growth (n = 7), a change in IA configuration (n = 2), or both (n = 1). Exploratory analyses of the effects of UIA size on diagnosis in terms of the hazard for a change of decision suggested an effect starting from 3 mm. No conservatively managed UIAs (n = 144) ruptured during the study period (median FU 24.5 months, IQR 7.75-55.75 months).
The likelihood of a shift to invasive UIA treatment is relatively low if a conservative therapeutic strategy was initially established. However, for cases with changes to the treatment strategy, the change is most often attributable to UIA growth over time. UIAs measuring < 3 mm at initial diagnosis are less likely to be later treated interventionally than those > 3 mm at diagnosis. Therefore, conservatively managed patients with UIAs should be closely monitored with regular radiographic FUs, particularly if the UIA measured > 3 mm at the time of diagnosis.
未破裂颅内动脉瘤(UIA)的治疗指征基于多个因素,如患者年龄、既往病史以及UIA的位置和大小。对于最初采用非侵入性管理的UIA患者,随访(FU)期间的治疗策略可改为包括手术或血管内介入治疗。本研究旨在确定需要修订初始管理策略的UIA的特征模式和潜在预测因素。
作者识别出2006年至2022年间新诊断的颅内动脉瘤(IA)病例,这些病例最初采用保守治疗。对这些病例进行回顾性分析,内容包括:1)诊断时的患者和UIA特征(患者年龄、合并症、既往病史、潜在危险因素以及UIA的血管结构、位置和大小);2)治疗策略的任何变化(改变的原因、干预前的时间、干预方式)。
在研究期间诊断的1041例IA病例中,144例最初采用保守治疗。在这144例病例中,有10例(6.9%)在中位随访26个月(IQR 8.5 - 64.5个月)后,治疗指征改为显微手术夹闭(n = 6)或血管内栓塞(n = 4)。在这10例病例中,干预指征归因于IA生长(n = 7)、IA形态改变(n = 2)或两者皆有(n = 1)。对UIA大小对诊断影响的探索性分析表明,从3mm开始就存在改变决策的风险。在研究期间(中位随访24.5个月,IQR 7.75 - 55.75个月),没有保守治疗的UIA(n = 144)破裂。
如果最初制定的是保守治疗策略,转为侵入性UIA治疗的可能性相对较低。然而,对于治疗策略发生改变的病例,这种改变最常见的原因是UIA随时间增长。初始诊断时直径< 3mm的UIA比诊断时直径> 3mm的UIA接受后续干预治疗的可能性更小。因此,对于采用保守治疗的UIA患者,应定期进行影像学随访密切监测,尤其是诊断时UIA直径> 3mm的患者。